Number of the records: 1  

Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia

  1. SYSr010567
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617130416.7
    100
      
    $a 20010910a2001 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia $f T. Robak, J. Góra-Tybor
    215
      
    $c Tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2001_001_003 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Roč. 48, č. 3 (2001), s. 203-207
    541
    1-
    $a Kladribín kombinovaný s mitoxantrónom pri liečbe blastickej fázy chronickej myeloidnej leukémie
    606
    0-
    $3 sllk_un_auth*d015464 $a leukémia myeloidná chronická, BCR-ABL pozitívna $x farmakoterapia $x terapia $2 mesh
    606
    0-
    $a mitoxantrón $x aplikácia a dávkovanie $x farmakokinetika $x použitie terapeutické $2 mesh $3 sllk_un_auth*d008942
    606
    0-
    $a kladribín $x aplikácia a dávkovanie $x farmakokinetika $x použitie terapeutické $2 mesh $3 sllk_un_auth*d017338
    606
    0-
    $a chemoterapia adjuvantná $x metódy $x trendy $x využitie $2 mesh $3 sllk_un_auth*d017024
    606
    0-
    $a kríza blastická $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d001752
    675
      
    $a 616.155.382:615.277 $v 1. stred. $z slo
    700
    -1
    $a Robak $b T. $3 sllk_un_auth*p0052366 $4 070 $p Department of Hematology, Medical University of Lodž, Lodž, Poland
    701
    -1
    $a Góra-Tybor $b J. $3 sllk_un_auth*p0061157 $4 070 $p Department of Hematology, Medical University of Lodž, Lodž, Poland
    801
    -0
    $a SK $b BA006 $c 20010910 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.